Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Emerging topics in FXTAS.

Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA.

J Neurodev Disord. 2014;6(1):31. doi: 10.1186/1866-1955-6-31. Epub 2014 Jul 30. Review. Erratum in: J Neurodev Disord. 2015;7(1):13.

2.

Fragile X-associated tremor/ataxia syndrome.

Hagerman PJ, Hagerman RJ.

Ann N Y Acad Sci. 2015 Mar;1338:58-70. doi: 10.1111/nyas.12693. Epub 2015 Jan 26. Review.

3.

COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Seritan A, Cogswell J, Grigsby J.

Curr Psychiatry Rev. 2013 Feb;9(1):78-84.

4.

Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.

Muzar Z, Adams PE, Schneider A, Hagerman RJ, Lozano R.

Intractable Rare Dis Res. 2014 Nov;3(4):162-5. doi: 10.5582/irdr.2014.01023.

5.

Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.

Ariza J, Steward C, Rueckert F, Widdison M, Coffman R, Afjei A, Noctor SC, Hagerman R, Hagerman P, Martínez-Cerdeño V.

Brain Res. 2015 Feb 19;1598:88-96. doi: 10.1016/j.brainres.2014.11.058. Epub 2014 Dec 9.

6.

Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.

Hukema RK, Buijsen RA, Raske C, Severijnen LA, Nieuwenhuizen-Bakker I, Minneboo M, Maas A, de Crom R, Kros JM, Hagerman PJ, Berman RF, Willemsen R.

Cell Cycle. 2014;13(16):2600-8. doi: 10.4161/15384101.2014.943112.

7.

Immune mediated disorders in women with a fragile X expansion and FXTAS.

Jalnapurkar I, Rafika N, Tassone F, Hagerman R.

Am J Med Genet A. 2015 Jan;167A(1):190-7. doi: 10.1002/ajmg.a.36748. Epub 2014 Nov 14.

8.

Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the field.

Hunsaker MR.

F1000Res. 2013 Dec 27;2:287. doi: 10.12688/f1000research.2-287.v1. eCollection 2013. Review.

9.

Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Hagerman R, Hagerman P.

Lancet Neurol. 2013 Aug;12(8):786-98. doi: 10.1016/S1474-4422(13)70125-X. Review.

10.

Unstable mutations in the FMR1 gene and the phenotypes.

Loesch D, Hagerman R.

Adv Exp Med Biol. 2012;769:78-114. Review.

11.

Immune-mediated disorders among women carriers of fragile X premutation alleles.

Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ.

Am J Med Genet A. 2012 Oct;158A(10):2473-81. doi: 10.1002/ajmg.a.35569. Epub 2012 Aug 17.

12.

Distribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutation.

Schluter EW, Hunsaker MR, Greco CM, Willemsen R, Berman RF.

Brain Res. 2012 Sep 7;1472:124-37. doi: 10.1016/j.brainres.2012.06.052. Epub 2012 Jul 11.

13.

Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS).

Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman RJ.

Am J Med Genet A. 2012 Jun;158A(6):1304-9. doi: 10.1002/ajmg.a.35323. Epub 2012 Apr 23.

14.

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ.

Genes Brain Behav. 2012 Jul;11(5):577-85. doi: 10.1111/j.1601-183X.2012.00779.x. Epub 2012 Apr 6.

15.

Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.

Hunsaker MR, Arque G, Berman RF, Willemsen R, Hukema RK.

Results Probl Cell Differ. 2012;54:255-69. doi: 10.1007/978-3-642-21649-7_14.

16.

The role of AGG interruptions in the transcription of FMR1 premutation alleles.

Yrigollen CM, Tassone F, Durbin-Johnson B, Tassone F.

PLoS One. 2011;6(7):e21728. doi: 10.1371/journal.pone.0021728. Epub 2011 Jul 19.

17.

Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.

Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F, Kros JM, Severijnen LA, Berry-Kravis EM, Berman RF, Hagerman PJ, Willemsen R, Hagerman RJ, Hukema RK.

Acta Neuropathol. 2011 Oct;122(4):467-79. doi: 10.1007/s00401-011-0860-9. Epub 2011 Jul 23.

18.

Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders.

Hunsaker MR, Greco CM, Tassone F, Berman RF, Willemsen R, Hagerman RJ, Hagerman PJ.

J Neuropathol Exp Neurol. 2011 Jun;70(6):462-9. doi: 10.1097/NEN.0b013e31821d3194.

19.

Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Hagerman R, Hoem G, Hagerman P.

Mol Autism. 2010 Sep 21;1(1):12. doi: 10.1186/2040-2392-1-12.

20.

Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome.

Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman RJ.

Hum Genet. 2010 Nov;128(5):539-48. doi: 10.1007/s00439-010-0882-8. Epub 2010 Sep 1.

Supplemental Content

Support Center